J, W., J, Z., B, Z., Y, Q., H, G., Y, Y., . . . Z, P. (2014). Polyethylene glycol–polylactic acid nanoparticles modified with cysteine–arginine–glutamic acid–lysine–alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect. Dove Medical Press.
Chicago Style (17th ed.) CitationJ, Wu, et al. Polyethylene Glycol–polylactic Acid Nanoparticles Modified with Cysteine–arginine–glutamic Acid–lysine–alanine Fibrin-homing Peptide for Glioblastoma Therapy by Enhanced Retention Effect. Dove Medical Press, 2014.
MLA (8th ed.) CitationJ, Wu, et al. Polyethylene Glycol–polylactic Acid Nanoparticles Modified with Cysteine–arginine–glutamic Acid–lysine–alanine Fibrin-homing Peptide for Glioblastoma Therapy by Enhanced Retention Effect. Dove Medical Press, 2014.